Tompkins Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Hold
1,000
0.02% 170
2026
Q1
$267K Hold
1,000
0.02% 170
2025
Q4
$251K Hold
1,000
0.02% 177
2025
Q3
$287K Hold
1,000
0.02% 157
2025
Q2
$263K Hold
1,000
0.02% 160
2025
Q1
$233K Hold
1,000
0.02% 174
2024
Q4
$229K Hold
1,000
0.02% 174
2024
Q3
$223K Buy
+1,000
New +$220K 0.02% 183
2024
Q2
Sell
-1,006
Closed -$220K 620
2024
Q1
$220K Hold
1,006
0.02% 188
2023
Q4
$229K Buy
1,006
+6
+0.6% +$1.26K 0.03% 182
2023
Q3
$201K Sell
1,000
-164
-14% -$34.6K 0.03% 172
2023
Q2
$241K Hold
1,164
0.04% 158
2023
Q1
$229K Hold
1,164
0.04% 162
2022
Q4
$235K Hold
1,164
0.04% 158
2022
Q3
$205K Hold
1,164
0.03% 165
2022
Q2
$234K Hold
1,164
0.04% 164
2022
Q1
$264K Buy
+1,164
New +$274K 0.04% 169

Other funds holding LH

Tompkins Financial's LH Position: Q2 2026 in Review

Tompkins Financial held its Labcorp (LH) position steady in Q2 2026 at 1,000 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #170.

Tompkins Financial first reported a position in LH in Q1 2022 and has held it in 17 quarters since. The position peaked at $287K in Q3 2025. 126 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Tompkins Financial held 1,000 shares of Labcorp worth $280K as of Q2 2026.
  • Tompkins Financial left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.02% of Tompkins Financial's portfolio in Q2 2026, its #170 holding.
  • Tompkins Financial first reported a position in Labcorp in Q1 2022 and has held it in 17 quarters since.
  • Tompkins Financial's Labcorp position peaked at $287K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.